サンプル依頼リスト カート
  • English
  • Korean
表紙：マイクロエレクトロニクス医療用インプラントの世界市場 - 2023年～2030年
市場調査レポート
商品コード
1374799

マイクロエレクトロニクス医療用インプラントの世界市場 - 2023年～2030年

Global Microelectronic Medical Implants Market -2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロエレクトロニクス医療用インプラントの世界市場 - 2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

個別化医療の発展が、マイクロエレクトロニクス医療用インプラントを含む、より高度な医療機器の需要を促進しています。患者の遠隔モニタリングの動向の高まりが、無線通信機能を備えたマイクロエレクトロニクス医療用インプラントの需要を促進しています。

マイクロエレクトロニクス技術が進化を続けるにつれ、医療分野での応用も増えています。埋め込み型医療機器は、新しいタイプの治療法へと広がり続けており、薬物療法に代わる選択肢の数を増やし続けています。心臓リズム管理製品は最も一般的なもので、ペーシング、除細動、心臓再同期化などに応用されています。新しい用途としては、パーキンソン病治療、疼痛管理、酸逆流モニター、失神モニターなどがあります。

さらに、マイクロエレクトロニクス医療用インプラント市場は、主要企業による新しいデバイスの発売、医療用インプラントの技術進歩、新興国における医療支出の増加など、さまざまな要因によって牽引されており、マイクロエレクトロニクス医療用インプラントメーカーにとって大きな成長機会となっています。

ダイナミクス

心血管疾患の有病率の上昇

冠動脈疾患、不整脈、心不全などの心血管疾患は、ペースメーカー、除細動器、心臓モニターなどの植え込み型機器を必要とすることが多いです。これらの疾患の有病率の増加は、心血管インプラントの需要を直接的に増加させる。

例えば、米国疾病予防管理センターの更新ファクトシート2023によると、米国では男性、女性、ほとんどの人種・民族の主な死因は心臓病です。米国では、33秒に1人が心血管疾患で死亡しています。

米国では2021年に約69万5,000人が心臓病で死亡し、死亡者の5人に1人を占める。2018年から2019年にかけて、米国は心臓病に約2億3,990万米ドルを費やしました。これは、ヘルスケアサービス、薬剤、死亡による生産性低下の費用をカバーしています。

技術の進歩

治療用神経インプラントは、脳のペースメーカーと同様に、ニューロンを正常な状態に回復させる電気刺激を発生させる。これらのインプラントは、CMOS技術を使って小型のシリコンチップに組み込まれ、装置の物理的寸法と消費電力を削減しています。

インプラントの高コスト

マイクロエレクトロニクス技術を用いた埋め込み型医療機器の開発・試験には多額の費用がかかるため、一部の患者やヘルスケアシステムにとって、これらの機器を購入しやすい価格や利用しやすい環境が制限されることがあります。

人工内耳手術は、小型で複雑な電子機器を耳の後ろの皮下に埋め込む医療処置です。この電子機器[人工内耳]は、聴覚神経を刺激し、患者が聞こえるようにするのに役立ちます。インドにおける人工内耳の費用は、6万5,870インドルピーから43万インドルピーであり、最大費用は87万3,600インドルピーに達します。平均費用も高くなります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 心房細動の有病率の上昇
      • 技術の進歩
    • 抑制要因
      • 面倒で時代遅れのホルター心電図分析
    • 機会
      • 新興市場での製品上市の増加
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 デバイスタイプ別

  • ペースメーカー・除細動器
  • 神経刺激装置
  • 埋め込み型薬物ポンプ
  • 脊髄融合刺激装置
  • 人工内耳
  • 眼インプラント
  • その他

第8章 用途別

  • 心臓病学
  • 神経学
  • 眼科
  • 整形外科
  • その他

第9章 技術別

  • RF技術
  • センサー
  • その他

第10章 エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Biotronik
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Boston Scientific Corporation
  • Abbott Laboratories
  • ZOLL Medical Corporation
  • Schiller
  • Medtronic
  • Lepu Medical
  • ZimVie
  • Stryker
  • Avantor, Inc

第14章 付録

目次
Product Code: MD7216

Overview

The development of personalized medicine is driving the demand for more sophisticated medical devices, including microelectronic medical implants. The growing trend towards remote patient monitoring is driving the demand for microelectronic medical implants with wireless communication capabilities.

As microelectronic technology continues to evolve, it is finding increased applications in the medical sector. Implantable medical devices are continuing to branch out to new types of therapies, posing a continuously growing number of alternatives to medication. Cardiac rhythm management products are the most common, with applications in pacing, defibrillation, and heart resynchronization. New applications include Parkinson's treatment, pain management, acid reflux monitors and syncope monitors.

Furthermore, the microelectronic medical implants market is driven by various factors like, new device launches by key players, technological advancements in medical implants, and increasing healthcare spending in emerging economies presents significant growth opportunities for microelectronic medical implant manufacturers.

Dynamics

Rise in the Prevalence of Cardiovascular Diseases

Cardiovascular diseases, such as coronary artery disease, arrhythmias, and heart failure, often require implantable devices like pacemakers, defibrillators, and cardiac monitors. The growing prevalence of these conditions directly increases the demand for cardiovascular implants.

For instance, according to the Centers for Disease Control and Prevention's updated factsheet 2023, heart disease is the main cause of death in the United States for men, women, and individuals of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 33 seconds.

Approximately 695,000 persons in the United States died from heart disease in 2021, accounting for one out of every five fatalities. From 2018 to 2019, the United States spent around $239.9 Million on heart disease. This covers the expense of healthcare services, medications, and lost productivity as a result of mortality.

Rise in the Technological Advancements

Therapeutic neural implants produce electrical stimulation to restore neurons to normal conditions, similar to a pacemaker for the brain. These implants are integrated into miniature silicon chips using CMOS technology, reducing the device's physical dimensions and power consumption.

High Cost of Implants

Developing and testing implantable medical devices with microelectronics technology can be expensive, limiting the affordability and accessibility of these devices for some patients and healthcare systems.

Cochlear Implant surgery is a medical procedure in which a small, complex electronic device is placed under the skin behind the ear. This electronic device [Cochlear implant] helps stimulate the auditory nerves and allows the patient to hear. The cost of a Cochlear Implant in India ranges from INR 65,870 to INR 4,30,000, with the maximum cost reaching INR 8,73,600. The average cost is also higher.

Segment Analysis

The global microelectronic medical implants market is segmented based on device type, application, technology, end-user and region.

The Pacemakers & Defibrillators Segment From the Device Type Segment Accounted For Approximately 41.7% of Microelectronic Medical Implants Share

The pacemakers & defibrillators segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. The computer circuits perform the functions of monitoring the patient's underlying heart rhythm and delivering an electrical signal to cause the heart to beat at the desired rate. Microelectronics plays a crucial role in pacemakers, a small, battery-powered device that controls the heart's rhythm. It requires precision manufacturing for proper function and has made pacemakers smaller, durable, and longer-lasting, making them more accessible and affordable.

For instance, in February 2023 Medtronic announced clinical data demonstrating significant improvements in Afib detection using the Reveal Linq. The study compared the Reveal Linq insertable cardiac monitor (ICM) to patients randomized to standard of care. Those patients did not receive continuous long-term monitoring.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors such as a rise in the number of FDA approvals for different products in the U.S., an increase in the prevalence of cardiac diseases, and the presence of favourable government policies in the region.

For instance, in August 2023 BIOTRONIK, a leader in implantable medical device technology, stated its first US implantation of the new Amvia Edge pacemaker.

Competitive Landscape

The major global players in the market include: Biotronik, Boston Scientific Corporation, Abbott Laboratories, ZOLL Medical Corporation, Schiller, Medtronic, Lepu Medical, ZimVie, Stryker, Avantor, Inc. and among others

Key Developments

  • In May 2023 Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.
  • In August 2021, Abbott Laboratories received FDA approval for its Infinity DBS system, a deep brain stimulation device used to treat Parkinson's disease and essential tremors. The device features advanced stimulation technology that allows for personalized therapy and real-time patient feedback.
  • In September 2021, LivaNova announced the launch of its next-generation Vagus Nerve Stimulation (VNS) therapy system for the treatment of epilepsy. The system features advanced simulation technology and offers patients a personalized approach to therapy.

COVID-19 Impact Analysis

The pandemic has resulted in a surge in demand for medical devices such as personal protective equipment, ventilators, and general hospital supplies. On the other hand, the postponement and cancellation of non-essential and elective procedures have impacted financially the manufacturers focusing on devices used in such procedures. The pandemic has also affected the supply chains of medical devices, including microelectronics, which may have caused initial shortages of deliveries.

Why Purchase the Report?

  • To visualize the global microelectronic medical implants market segmentation based on device type, application, technology, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global microelectronic medical implants market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global microelectronic medical implants market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Atrial Fibrillation
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Tedious And Outdated Holter ECG Analysis
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in the Product Launches in Emerging Markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Pacemakers & Defibrillators*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Neurostimulators
  • 7.4. Implantable Drug Pumps
  • 7.5. Spinal Fusion Stimulators
  • 7.6. Cochlear Implants
  • 7.7. Ocular Implants
  • 7.8. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Neurology
  • 8.4. Ophthalmology
  • 8.5. Orthopedics
  • 8.6. Others

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. RF Technology*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Sensors
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Biotronik *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Boston Scientific Corporation
  • 13.3. Abbott Laboratories
  • 13.4. ZOLL Medical Corporation
  • 13.5. Schiller
  • 13.6. Medtronic
  • 13.7. Lepu Medical
  • 13.8. ZimVie
  • 13.9. Stryker
  • 13.10. Avantor, Inc

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us